Danuglipron Danuglipron is a small-molecule GLP-1 receptor agonist, formerly under development by Pfizer [1] that, in an oral formulation, was under investigation as a therapy for diabetes mellitus
There may also be a requirement to return to the initial dose and gradually build up to the maintenance dose again, even if you reached the maintenance dose of Wegovy or Ozempic previously
GLP-1 is a peptide your body releases when you eat, and it causes your pancreas to create insulin to gobble up the glucose that food sends into your bloodstream
Learn more about surgical weight loss at Via Christi Weight Management or call 316-689-5232
Fatty fish like salmon, sardines, and mackerel are also phenomenal sources of Omega-3s that support both brain and metabolic health
Inform healthcare providers about all medications and substances you are using